Cardiovascular Systems (CSII) Posts Smaller-Than-Expected Q2 Loss

Cardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.17), $0.18 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $44.7 million versus the consensus estimate of $43.97 million.

Cardiovascular Systems sees Q3 2015 EPS of ($0.32)-($0.35), versus the consensus of ($0.33). Cardiovascular Systems sees Q3 2015 revenue of $46-47.7 million, versus the consensus of $46.2 million.

David L. Martin, CSI’s President and Chief Executive Officer, said, “Our unique orbital atherectomy technology for the treatment of peripheral and coronary artery disease continues to gain adoption in the vastly underserved, multi-billion dollar calcified artery disease markets, driving year-over-year revenue growth of more than 30 percent in the last four consecutive quarters.”

For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.

You May Also Be Interested In

• SAP Q1 results fall short of Wall Street estimates as transformation kicks off
• Globe Life Inc. (GL) Misses Q1 EPS by 1c, Offers Guidance
• SmartFinancial (SMBK) Tops Q1 EPS by 8c